1-6 of 6
Neal Lindeman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry

Mari Mino-Kenudson, Lucian R. Chirieac, Kenny Law, Jason L. Hornick, Neal Lindeman, Eugene J. Mark, David W. Cohen, Bruce E. Johnson, Pasi A. Jänne, A. John Iafrate, Scott J. Rodig
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1561–1571.
https://doi.org/10.1158/1078-0432.CCR-09-2845
Published: 28 February 2010
View article titled, A Novel, Highly Sensitive Antibody Allows for the Routine Detection of <em>ALK</em>-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
Open the PDF for A Novel, Highly Sensitive Antibody Allows for the Routine Detection of <em>ALK</em>-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry in another window
Includes: Supplementary data
Journal Articles

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

Scott J. Rodig, Mari Mino-Kenudson, Sanja Dacic, Beow Y. Yeap, Alice Shaw, Justine A. Barletta, Hannah Stubbs, Kenny Law, Neal Lindeman, Eugene Mark, Pasi A. Janne, Thomas Lynch, Bruce E. Johnson, A. John Iafrate, Lucian R. Chirieac
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5216–5223.
https://doi.org/10.1158/1078-0432.CCR-09-0802
Published: 12 August 2009
View article titled, Unique Clinicopathologic Features Characterize <em>ALK</em>-Rearranged Lung Adenocarcinoma in the Western Population
Open the PDF for Unique Clinicopathologic Features Characterize <em>ALK</em>-Rearranged Lung Adenocarcinoma in the Western Population in another window
Includes: Supplementary data
Journal Articles

Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers

Kimio Yonesaka, Kreshnik Zejnullahu, Neal Lindeman, Alison J. Homes, David M. Jackman, Feng Zhao, Andrew M. Rogers, Bruce E. Johnson, Pasi A. Jänne
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 6963–6973.
https://doi.org/10.1158/1078-0432.CCR-08-0957
Published: 03 November 2008
View article titled, Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <em>EGFR</em> Wild-type Cancers
Open the PDF for Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in <em>EGFR</em> Wild-type Cancers in another window
Includes: Supplementary data
Journal Articles

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Jussi P. Koivunen, Craig Mermel, Kreshnik Zejnullahu, Carly Murphy, Eugene Lifshits, Alison J. Holmes, Hwan Geun Choi, Jhingook Kim, Derek Chiang, Roman Thomas, Jinseon Lee, William G. Richards, David J. Sugarbaker, Christopher Ducko, Neal Lindeman, J. Paul Marcoux, Jeffrey A. Engelman, Nathanael S. Gray, Charles Lee, Matthew Meyerson, Pasi A. Jänne
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4275–4283.
https://doi.org/10.1158/1078-0432.CCR-08-0168
Published: 01 July 2008
View article titled, <em>EML4-ALK</em> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer
Open the PDF for <em>EML4-ALK</em> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

David M. Jackman, Beow Y. Yeap, Lecia V. Sequist, Neal Lindeman, Alison J. Holmes, Victoria A. Joshi, Daphne W. Bell, Mark S. Huberman, Balazs Halmos, Michael S. Rabin, Daniel A. Haber, Thomas J. Lynch, Matthew Meyerson, Bruce E. Johnson, Pasi A. Jänne
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3908–3914.
https://doi.org/10.1158/1078-0432.CCR-06-0462
Published: 03 July 2006
View article titled, Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
Open the PDF for Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib in another window
Journal Articles

A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening

Pasi A. Jänne, Ana M. Borras, Yanan Kuang, Andrew M. Rogers, Victoria A. Joshi, Hema Liyanage, Neal Lindeman, Jeffrey C. Lee, Balazs Halmos, Elizabeth A. Maher, Robert J. Distel, Matthew Meyerson, Bruce E. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 751–758.
https://doi.org/10.1158/1078-0432.CCR-05-2047
Published: 07 February 2006
View article titled, A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening
Open the PDF for A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening in another window